European Network of AI Excellence Centres (ELISE) 1st open call
Ellogon.AI’s co-founder Efstratios Gavves has been interviewed by the European Network of AI Excellence Centres (ELISE) as the company was part of ELISE 1st Open Call.
Read the interview: https://www.elise-ai.eu/events/using-artificial-intelligence-to-select-the-right-cancer-patients-for-immunotherapy
KWF grant together with Amsterdam UMC, NKI and UvA12 January 2023
KWF grant together with Amsterdam UMC, NKI and UvA 12 January 2023 Jessica We are happy to announce that Ellogon.AI has received a KWF grant together with the Amsterdam UMC,…
EIDOS runs on UbiOps29 December 2022
EIDOS runs on UbiOps 29 December 2022 Jessica Hot off the press! Working with the Netherlands Cancer Institute, Ellogon.AI has developed a faster and more efficient method of…
WeakSTIL: Weak whole-slide image level stromal tumor infiltrating lymphocyte scores are all you need4 April 2022
Scientific publication by Yoni Schirris, PhD student of the HISTO-AI project.